What is Yescarta?
Yescarta is an immunotherapy medicine used to treat large B-cell lymphoma when your first treatment did not work or your cancer returned within a year of first treatment, OR when at least two kinds of treatment have failed to control your cancer.
Yescarta is also used to treat follicular lymphoma when at least two kinds of treatment have failed to control your cancer.
Large B-cell lymphoma and follicular lymphoma are both two types of non-Hodgkin lymphoma.
Yescarta is made using white blood cells removed from blood that is drawn from your body through a vein.
Yescarta is available under a special program. You must be registered in the program and understand the risks and benefits of this medicine.
A serious side effect of Yescarta is called cytokine release syndrome, which causes fever, chills, trouble breathing, vomiting, and other symptoms. Your caregivers will have medication available to quickly treat this condition if it occurs.
Yescarta can also cause life-threatening nerve problems. Tell your caregivers or seek emergency medical attention if you have problems with speech, problems with thinking or memory, confusion, or a seizure.
Before taking this medicine
To make sure Yescarta is safe for you, tell your doctor if you have ever had:
an active or chronic infection;
liver or kidney disease;
a stroke; or
if you have received a vaccine in the past 2 weeks.
If you receive Yescarta during pregnancy, your baby's blood may need to be tested after it is born. This is to evaluate any effects the medicine may have had on the baby.
It may not be safe to breastfeed while using this medicine. Ask your doctor about any risk.
How is Yescarta given?
Yescarta is available only at an authorized hospital or clinic, and must be given by specially trained healthcare professionals.
Yescarta is given after a procedure called leukapheresis (LOO-kuh-fuh-REE-sis).
During leukapheresis, some of your blood is collected through a small tube (catheter) placed into a vein. The catheter is connected to a machine that separates your white blood cells from other parts of the blood.
The cells are then sent to a laboratory where they are made into Yescarta. Because it will take time to process your blood cells into axicabtagene ciloleucel, you will not receive the medicine on the same day your blood cells are drawn.
About 3 to 5 days before Yescarta is given, you will be pre-treated with chemotherapy to help prepare your body for administration of this medicine.
Just before you receive this medicine, you will be given other medications to help prevent serious side effects or allergic reaction.
Once your body is ready to receive Yescarta, your care providers will inject the medicine into a vein through an IV.
You will be watched closely for at least 7 days after you receive Yescarta, to make sure you do not have an allergic reaction or serious side effects.
You will need frequent blood tests to be sure this medicine has not caused harmful effects.
For at least 4 weeks, plan to stay near the hospital or clinic where you received Yescarta. Avoid being so far away that it takes you longer than 2 hours to travel back to the hospital.
Usual Adult Dose for Lymphoma:
2 x 106 chimeric antigen receptor (CAR)-positive viable T cells IV per kg body weight via IV infusion; infuse within 30 minutes
Maximum Dose: 2 x 108 CAR-positive viable T cells
-Pretreatment: Administer a lymphodepleting chemotherapy regimen of cyclophosphamide 500 mg/m2 IV and fludarabine 30 mg/m2 IV on the fifth, fourth, and third day before infusion of this drug.
-Premedication: Administer acetaminophen 650 mg orally and diphenhydramine 12.5 mg IV or orally approximately 1 hour before infusion of this drug.
-Avoid prophylactic use of systemic corticosteroids as it may interfere with the activity of this drug.
Use: Treatment of relapsed or refractory large B-cell lymphoma that is refractory to first-line chemoimmunotherapy or that relapses within 12 months of first-line chemoimmunotherapy; treatment of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell lymphoma, high grade B-cell lymphoma, and DLBCL arising from follicular lymphoma; and treatment of relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy.
What happens if I miss a dose?
Call your doctor for instructions if you miss any of your chemotherapy treatment, or if you miss a dose of your medications to prevent side effects of axicabtagene ciloleucel.
What happens if I overdose?
Since this medicine is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.
What should I avoid after receiving Yescarta?
This medicine can cause weakness, drowsiness, confusion, problems with memory or coordination, and seizures. Avoid driving or operating machinery for at least 8 weeks after you are treated with Yescarta.
Ask your doctor before you receive a "live" vaccine. Live vaccines include measles, mumps, rubella (MMR), polio, rotavirus, typhoid, yellow fever, varicella (chickenpox), zoster (shingles), and nasal flu (influenza) vaccine.
Do not donate blood, an organ, or any tissues or cells from your own body.
Yescarta side effects
Get emergency medical help if you have signs of an allergic reaction to Yescarta: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
A serious side effect of axicabtagene ciloleucel is called cytokine release syndrome (CRS). Tell your caregivers right away if you have signs of this condition: fever, chills, trouble breathing, confusion, severe vomiting or diarrhea, fast or irregular heartbeats, feeling light-headed, or feeling very weak or tired. Your caregivers will have medication available to quickly treat CRS if it occurs.
Also tell your caregivers or seek emergency medical attention if you have signs of life-threatening nerve problems: problems with speech, problems with thinking or memory, confusion, or a seizure.
Also call your doctor at once if you have:
tremors, anxiety, trouble sleeping;
unusual thoughts or behavior;
trouble speaking or understanding what is said to you; or
low blood cell counts - fever, chills, tiredness, flu-like symptoms, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath.
Common Yescarta side effects may include:
low blood cells;
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What other drugs will affect Yescarta?
Other drugs may interact with axicabtagene ciloleucel, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Where can I get more information?
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Yescarta only for the indication prescribed.
The cost of Yescarta, as reported by the manufacturer, is $373,000 per treatment regimen. CAR T cell development is a complicated bioengineering process and this personalized cancer treatment is expected to be costly. Specialized facilities, manufacturing costs, and possible intensive care needs can also contribute to the cost of this medication. Continue reading
Yescarta (axicabtagene ciloleucel) is given through a catheter placed into your vein (intravenous infusion). The infusion usually takes less than 30 minutes and is given as a one-time infusion. Yescarta is administered only in a certified healthcare facility. Continue reading
Yescarta (axicabtagene ciloleucel) is a CD19-directed chimeric antigen receptor T cell (CAR T) therapy used for adults with relapsed or refractory (r/r) large B-cell lymphoma and r/r follicular lymphoma (FL). In CAR T, a patient's T cells (type of white blood cell) are separated out and engineered to express a chimeric antigen receptor (CAR) to target the tumor antigen CD19. Continue reading
More about Yescarta (axicabtagene ciloleucel)
- Check interactions
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2022 Cerner Multum, Inc. Version: 1.02.